Les Funtleyder Recommends Intuitive Surgery, Merck

Les Funtleyder Recommends Intuitive Surgery, Merck Play

March 12 (Bloomberg) -- Les Funtleyder, an analyst at Miller Tabak & Co., talks about Asahi Kasei Corp.'s agreement to buy Zoll Medical Corp. for $2.2 billion and his investment strategy for health-care shares. He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus